Canvax Biotech has recently received an endorsement from the Ministry of Economy and Competitiveness (MINECO) through the RETOS-COLABORACIÓN Program. Canvax Biotech will lead the consortium composed by Villapharma Research from Murcia, Instituto de Investigación Biomédica of Bellvitge (IDIBELL), two scientific groups from Instituto de Investigación Biomédica of Córdoba (IMIBIC) and two groups from Universidad de Granada.
The project, STEMHIT, is focused on a drug discovery program targeting cancer stem cells and in the preclinical characterization of the molecules developed, using the expertise from the participant entities. Through RETOS Project, Canvax consolidates its partnership with Villapharma, a CRO from Murcia specialized on the synthesis of new molecules for the pharmaceutical industry and medicinal chemistry and, besides, Canvax bet again on collaboration with leading research groups within the public sector.
RETOS program provides funds in the form of subventions to three partners from public centres: IDIBELL (132.179 €), IMIBIC (96.572 €) and Universidad de Granada (UGR) (124.179 €). Private companies receive funds in the form of loans.